Daniela A. Bota
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study Of NOVOTTF-200A In Bevacizumab-Naive Subjects With Recurrent Grade III Malignant Astrocytoma (NCT03450850) | Daniela A. Bota | 2020-05-21 |
Track Daniela A. Bota automatically
Every clearance here is in the API, with alerts when new ones post.